Skip to main content
padlock icon - secure page this page is secure

Adult Primary Immune Thrombocytopenia

Buy Article:

$62.00 + tax (Refund Policy)

Immune thrombocytopenia (ITP) is an acquired antibody-mediated disease, for which splenectomy remains a curative treatment. We analyzed histology and phenotypes of ITP-splenectomy specimens from 41 adult patients, with different previous ITP-specific treatments, including B-cell–depleting rituximab (RTX) or not, in an attempt to predict splenectomy success or failure on the basis of day 56 postoperative platelet counts. RTX-naive ITP-spleen samples, compared with those from a 20-patient control trauma cohort, contained the following nonspecific, ITP-evocative, white-pulp lesions: follicular helper T-cell (programmed death-1+ and inducible T-cell COStimulator+) expansion in reactive follicles (P=0.01 and 0.03, respectively) and regulatory T-cell (FOXP3+) expansion in the T-cell zone (P=0.049). On comparing ITP-splenectomy samples that would be successful with those that would be failures, only marginal zone hyperplasia differed (P=0.017). Indeed, 13/21 (61.9%) successful splenectomy samples exhibited marginal zone hyperplasia, as opposed to 1/9 (11.1%) failed splenectomy specimens. RTX impact on ITP-splenectomy samples was characterized by white-pulp (P=0.03) and marginal zone atrophies (P=0.01), and periarteriolar T-cell–zone hyperplasia (P<0.0001). The results of this novel comparative study of the histologic patterns of 41 ITP patients’ evocative splenic lesions enabled clear description of different ITP morphologies and phenotypes, as a function of prior treatment and splenectomy success or failure.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: immune thrombocytopenia; immunochemistry; rituximab; spleen pathology; splenectomy

Document Type: Research Article

Affiliations: 1: Pathology Department, Medical School 2: Medical School, Internal Medicine Department, Haut-Lévêque Hospital, University Hospital Center of Bordeaux, INSERM U1034 3: Medical School, INSERM U1034 4: Medical School, Intensive Care Unit, Bordeaux University Hospital, Pessac 5: Pathology Department, Medical School, Bariton Unit, University of Bordeaux, Bordeaux, France

Publication date: March 1, 2018

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more